Abstract: The present invention relates to substituted quinazolines of formula (I) wherein X and Y are defined as in claim 1, the tautomers, stereoisomers, mixtures and salts thereof, which have valuable pharmacological properties, particularly an inhibitory effect on the activity of the enzyme dipeptidylpeptidase-IV (DPP-IV).
Type:
Grant
Filed:
December 23, 2014
Date of Patent:
December 1, 2015
Assignee:
Boehringer Ingelheim Internatioal GmbH
Inventors:
Waldemar Pfrengle, Markus Frank, Thomas Klein